ArabFinance: Macro Group Pharmaceutical (Macro Capital) (MCRO) posted a 9.5% profit increase during the full year ended December 31st 2021, according to financial indicators filed to the Egyptian Exchange (EGX) on Sunday.
The company’s net profit after tax grew to EGP 147.967 million in 2021, from EGP 135.129 million in 2020.
Revenue soared to EGP 594.259 million in 2021, from EGP 430.503 million the year before.
Founded in 2002, Macro Group is a leading Egyptian cosmeceutical company based in Cairo.